“We know now from watching COVID and how it affects us that Americans are more vulnerable than any other population and that obesity is the number one underlying factor for Americans, which is a signifier of poor metabolic health,” Kenyon said. Instead, Calibrate focuses on treating patients’ underlying metabolic health, which controls everything from cholesterol levels and stress reactions to emotional health and weight management. “Six months ago, metabolic health was America’s pandemic, and now it is definitely America’s pandemic,” Kenyon said. “Almost 9 out of 10 Americans don’t qualify as having good metabolic health.” But she quickly realized that consumer healthcare was an entirely different beast when it came to courting Silicon Valley investors.
Source: Startup Around
